Cargando…

Influenza B Lineages Have More in Common Than Meets the Eye. Trivalent Influenza Vaccines Trigger Heterotypic Antibodies Against Both Influenza B Viruses

Influenza B is accountable for an important burden during flu epidemics, causing special impact in children and the elderly. Vaccination is the best approach to address influenza infections. However, one of the main problems of this virus is that two different lineages circulate together, Victoria a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sánchez-de Prada, Laura, Rojo-Rello, Silvia, Domínguez-Gil, Marta, Tamayo-Gómez, Eduardo, Ortiz de Lejarazu-Leonardo, Raúl, Eiros, José María, Sanz-Muñoz, Iván
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Microbiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8632244/ https://www.ncbi.nlm.nih.gov/pubmed/34858361 http://dx.doi.org/10.3389/fmicb.2021.737216

Ejemplares similares

Do Vaccines Need a Gender Perspective? Influenza Says Yes!
por: Sánchez-de Prada, Laura, et al.
Publicado: (2021)

Immunodominance hierarchy after seasonal influenza vaccination
por: Sánchez-de Prada, Laura, et al.
Publicado: (2022)

Heterotypic Neuraminidase Antibodies Against Different A(H1N1) Strains are Elicited after Seasonal Influenza Vaccination
por: Mendez-Legaza, Jose Manuel, et al.
Publicado: (2019)

Influenza B vaccine lineage selection—An optimized trivalent vaccine
por: Mosterín Höpping, Ana, et al.
Publicado: (2016)

Adjuvanted Influenza Vaccines Elicits Higher Antibody Responses against the A(H3N2) Subtype than Non-Adjuvanted Vaccines
por: Sánchez de Prada, Laura, et al.
Publicado: (2020)

Heterologous Humoral Response against H5N1, H7N3, and H9N2 Avian Influenza Viruses after Seasonal Vaccination in a European Elderly Population
por: Sanz, Ivan, et al.
Publicado: (2017)

Influenza B Virus Infection Is Enhanced Upon Heterotypic Co-infection With Influenza A Virus
por: Malausse, Nicolas, et al.
Publicado: (2021)

Interim effectiveness of trivalent influenza vaccine in a season dominated by lineage mismatched influenza B, northern Spain, 2017/18
por: Castilla, Jesús, et al.
Publicado: (2018)

Global influenza surveillance in times of COVID-19: Robbing Peter to pay Paul?()
por: Sanz-Muñoz, I., et al.
Publicado: (2021)

From trivalent to quadrivalent influenza vaccines: Public health and economic burden for different immunization strategies in Spain
por: Crépey, Pascal, et al.
Publicado: (2020)

Estimating the burden of seasonal influenza in Spain from surveillance of mild and severe influenza disease, 2010‐2016
por: Oliva, Jesús, et al.
Publicado: (2017)

Impact of adjuvant: Trivalent vaccine with quadrivalent-like protection against heterologous Yamagata-lineage influenza B virus
por: Myers, Mallory L., et al.
Publicado: (2022)

Long-term influenza antibodies profiles in previously vaccinated and non-vaccinated adults
por: Sanz-Muñoz, Iván, et al.
Publicado: (2023)

Corrigendum: Impact of adjuvant: trivalent vaccine with quadrivalent-like protection against heterologous Yamagata-lineage influenza B virus
por: Myers, Mallory L., et al.
Publicado: (2023)

Immunopathogenesis of 2009 pandemic influenza
por: Almansa, Raquel, et al.
Publicado: (2012)

Possible Mpox Protection from Smallpox Vaccine–Generated Antibodies among Older Adults
por: Sanz-Muñoz, Iván, et al.
Publicado: (2023)

Molecular Markers of Influenza B Lineages and Clades
por: Arvia, Rosaria, et al.
Publicado: (2014)

25. Relative Effectiveness of Adjuvanted Trivalent Influenza Vaccine Compared to Egg-Based Trivalent High-Dose Influenza Vaccine among U.S. Older Adults during 2019-20 Influenza Season
por: levin, myron J, et al.
Publicado: (2021)

Relative Vaccine Effectiveness of Adjuvanted Trivalent Influenza Vaccine over Three Consecutive Influenza Seasons in the United States
por: Boikos, Constantina, et al.
Publicado: (2022)

29. Impact of Enhanced Influenza Vaccines on Direct Healthcare Costs for the U.S. Elderly: A Comprehensive Real-World Evaluation of Adjuvanted Trivalent Influenza Vaccine Compared to Trivalent High-Dose Influenza Vaccine for the 2018–19 Influenza Season
por: Postma, Maarten, et al.
Publicado: (2020)

Public health and economic impact of seasonal influenza vaccination with quadrivalent influenza vaccines compared to trivalent influenza vaccines in Europe
por: Uhart, Mathieu, et al.
Publicado: (2016)

Cost–effectiveness analysis of quadrivalent influenza vaccine in Spain
por: García, Amos, et al.
Publicado: (2016)

Evaluating the Relative Vaccine Effectiveness of Adjuvanted Trivalent Influenza Vaccine Compared to High-Dose Trivalent and Other Egg-Based Influenza Vaccines among Older Adults in the US during the 2017–2018 Influenza Season
por: Pelton, Stephen I., et al.
Publicado: (2020)

BTLA expression declines on B cells of the aged and is associated with low responsiveness to the trivalent influenza vaccine
por: Kannan, Senthil, et al.
Publicado: (2015)

Estimating the Lineage Dynamics of Human Influenza B Viruses
por: Nyirenda, Mayumbo, et al.
Publicado: (2016)

Variation in Influenza B Virus Epidemiology by Lineage, China
por: Yang, Juan, et al.
Publicado: (2018)

El enterovirus D68 sí que existe en España
por: Rojo-Rello, Silvia, et al.
Publicado: (2016)

14. A Comprehensive Real-World Analysis to Compare Adjuvanted Trivalent Influenza Vaccine and Trivalent High Dose Influenza Vaccine by Age and Period of High Influenza Activity for the 2018–19 Season among U.S. Elderly
por: Postma, Maarten, et al.
Publicado: (2020)

Cross-Lineage Influenza B and Heterologous Influenza A Antibody Responses in Vaccinated Mice: Immunologic Interactions and B/Yamagata Dominance
por: Skowronski, Danuta M., et al.
Publicado: (2012)

Cost-effectiveness analysis of quadrivalent influenza vaccine versus trivalent influenza vaccine for elderly in Hong Kong
por: You, Joyce HS, et al.
Publicado: (2014)

Relative Effectiveness of MF59 Adjuvanted Trivalent Influenza Vaccine vs Nonadjuvanted Vaccines During the 2019–2020 Influenza Season
por: Imran, Mahrukh, et al.
Publicado: (2022)

Acquired immune responses to the seasonal trivalent influenza vaccination in COPD
por: Staples, K. J., et al.
Publicado: (2019)

Gulllain-Barre Syndrome After Trivalent Influenza Vaccination in Adults
por: Chang, Kuo-Hsuan, et al.
Publicado: (2019)

Assessment of trivalent live influenza vaccines in MDCK cell line
por: Landgraf, G., et al.
Publicado: (2021)

Nucleoprotein vaccine induces cross-protective cytotoxic T lymphocytes against both lineages of influenza B virus
por: Lee, So-Young, et al.
Publicado: (2019)

Relative Effectiveness of Adjuvanted Trivalent Inactivated Influenza Vaccine Versus Egg-derived Quadrivalent Inactivated Influenza Vaccines and High-dose Trivalent Influenza Vaccine in Preventing Influenza-related Medical Encounters in US Adults ≥ 65 Years During the 2017–2018 and 2018–2019 Influenza Seasons
por: Boikos, Constantina, et al.
Publicado: (2021)

Influenza hospitalizations in children under 1 year old in Spain: the importance of maternal immunization
por: San Román Montero, Jesús, et al.
Publicado: (2020)

Enhanced Inhibition of Influenza A Virus Adhesion by Di- and Trivalent Hemagglutinin Inhibitors
por: Lu, Wenjing, et al.
Publicado: (2019)

531 Split-virion compared to Subunit Influenza Trivalent Influenza Vaccines Has Greater Effectiveness in Older Adults
por: Talbot, H. Keipp, et al.
Publicado: (2014)

Cost Effectiveness of Quadrivalent Influenza Vaccines Compared with Trivalent Influenza Vaccines in Young Children and Older Adults in Korea
por: Kim, Yun-Kyung, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_sdqovsk7pndsiapmu08o1uhmho